Increased Risk of Dementia in Patients With Chronic Obstructive Pulmonary Disease

被引:73
作者
Liao, Kuang-Ming [1 ,2 ]
Ho, Chung-Han [3 ,4 ]
Ko, Shian-Chin [5 ]
Li, Chung-Yi [6 ,7 ]
机构
[1] Chi Mei Med Ctr, Dept Internal Med, Chiali, Taiwan
[2] Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Tainan 70101, Taiwan
[3] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan
[4] Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm, Tainan, Taiwan
[5] Chi Mei Med Ctr, Dept Chest Med, Tainan, Taiwan
[6] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan 704, Taiwan
[7] China Med Univ, Coll Publ Hlth, Dept Publ Hlth, Taichung, Taiwan
关键词
MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; ALZHEIMER-DISEASE; PARKINSONS-DISEASE; DIABETES-MELLITUS; ASSOCIATION; DECLINE;
D O I
10.1097/MD.0000000000000930
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Neurodegenerative disease in patients with chronic obstructive pulmonary disease (COPD) was observed. We aim to clarify the risk of dementia in patients with COPD.The study used claims data from Taiwan's National Health Insurance Research Database. Subjects were those who received a discharge diagnosis of COPD between January 1, 2002 and December 31, 2011. Only the first hospitalization was enrolled, and the index date was the first day of admission. Patients younger than 40 years or those with a history of Alzheimer disease (AD) or Parkinson disease (PD) before the index date were excluded. The patients with COPD were then followed until receiving a diagnosis of AD or PD, death, or the end of the study. Control subjects were selected from hospitalized patients without a history of COPD, AD, or PD and were matched according to age (3 years), gender, and the year of admission at a 2:1 ratio. The comorbidities were measured from 1 year before the index date based on the ICD-9-CM codes. The study included 8640 patients with COPD and a mean age of 68.76 (+/- 10.74) years. The adjusted hazard ratio of developing dementia (AD or PD) was 1.74 (95% confidence interval=1.55-1.96) in patients with COPD compared with patients without COPD after adjusting for age, gender, and comorbidities.This nationwide cohort study demonstrates that the risk of dementia, including AD and PD, is significantly increased in patients with COPD compared with individuals in the general population.
引用
收藏
页数:5
相关论文
共 23 条
[1]
Diabetes mellitus and risk of developing Alzheimer disease - Results from the Framingham study [J].
Akomolafe, Abimbola ;
Beiser, Alexa ;
Meigs, Phdjames B. ;
Au, Rhoda ;
Green, Robert C. ;
Farrer, Lindsay A. ;
Wolf, Philip A. ;
Seshadri, Sudha .
ARCHIVES OF NEUROLOGY, 2006, 63 (11) :1551-1555
[2]
Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function [J].
Arvanitakis, Z ;
Wilson, RS ;
Bienias, JL ;
Evans, DA ;
Bennett, DA .
ARCHIVES OF NEUROLOGY, 2004, 61 (05) :661-666
[3]
Prevalence, severity and underdiagnosis of COPD in the primary care setting [J].
Bednarek, M. ;
Maciejewski, J. ;
Wozniak, M. ;
Kuca, P. ;
Zielinski, J. .
THORAX, 2008, 63 (05) :402-407
[4]
Confirmatory spirometry for adults hospitalized with a diagnosis of asthma or chronic obstructive pulmonary disease exacerbation [J].
Centurion, Valentin Prieto ;
Huang, Frank ;
Naureckas, Edward T. ;
Camargo, Carlos A., Jr. ;
Charbeneau, Jeffrey ;
Joo, Min J. ;
Press, Valerie G. ;
Krishnan, Jerry A. .
BMC PULMONARY MEDICINE, 2012, 12
[5]
Alzheimer disease and risk of stroke A population-based cohort study [J].
Chi, Nai-Fang ;
Chien, Li-Nien ;
Ku, Hsiao-Lun ;
Hu, Chaur-Jong ;
Chiou, Hung-Yi .
NEUROLOGY, 2013, 80 (08) :705-711
[6]
Critical threshold cerebral hypoperfusion causes Alzheimer's disease? [J].
de la Torre, JC .
ACTA NEUROPATHOLOGICA, 1999, 98 (01) :1-8
[7]
Cognitive function in COPD [J].
Dodd, J. W. ;
Getov, S. V. ;
Jones, P. W. .
EUROPEAN RESPIRATORY JOURNAL, 2010, 35 (04) :913-922
[8]
NEUROPSYCHOLOGIC FINDINGS IN HYPOXEMIC CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
GRANT, I ;
HEATON, RK ;
MCSWEENY, AJ ;
ADAMS, KM ;
TIMMS, RM .
ARCHIVES OF INTERNAL MEDICINE, 1982, 142 (08) :1470-1476
[9]
New therapeutic strategies and drug candidates for neurodegenerative diseases p53 and TNF-α inhibitors, and GLP-1 receptor agonists [J].
Greig, NH ;
Mattson, MP ;
Perry, T ;
Chan, SL ;
Giordano, T ;
Sambamurti, K ;
Rogers, JT ;
Ovadia, H ;
Lahiri, DK .
PROTECTIVE STRATEGIES FOR NEURODEGENERATIVE DISEASES, 2004, 1035 :290-315
[10]
Hnizdo Eva, 2006, COPD, V3, P95, DOI 10.1080/15412550600651552